Sponsor

Treeline Biosciences Inc.

United States 500 Arsenal Street, 02472-2806, United States

About the sponsor

Treeline Biosciences Inc. is active in oncology research centered on locally advanced and metastatic solid tumors, with attention to cancers that remain difficult to control once they have spread beyond the primary site.

Advanced solid cancers
Metastatic disease
Tumor progression

The sponsor’s clinical work in this area reflects a focused interest in treatment options for patients with advanced-stage malignancies.

About Specializations

Treeline Biosciences Inc. runs clinical trials in conditions such as Neoplasm malignant, among others.

Neoplasm malignant

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Neoplasm malignant

Recruiting

Registered drugNo placebo

A study to test the safety and effects of TLN-372 alone and with other cancer drugs in patients with advanced solid tumors with KRAS gene changes

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cetuximab
Sponsor:Treeline Biosciences Inc.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →